“…[12][13][14][15] Consequences include effects on tumor growth, escape from apoptosis,m etastasis formation, and resistance to therapy.P olysaccharides involved in the glycosylation procedure have ah ighly conserved simple composition and are ubiquitously expressed in all animals that have ad eveloped immune response.T he natural production of antibodies that specifically recognize these "weak antigens" is difficult; [16] hence,traditional immunohistochemical methods for detecting glycosylations on cells are rare.A na lternative would be "plastic antibodies" or MIPs. [17,18] MIPs are tailormade synthetic antibody mimics that can recognize and bind target molecules specifically.They are synthesized by copolymerizing functional and cross-linking monomers in the presence of am olecular template,t hus resulting in the formation of binding sites with affinities and specificities comparable to those of natural antibodies.T heir molecularrecognition properties,c ombined with ah igh chemical and physical stability,m ake them interesting substitutes for antibodies in immunoassays, [19] biosensors, [20] bioseparation, [18,21] controlled drug release, [22] and bioimaging. [23][24][25] In this study,M IP-coated QDs were applied for the first time for the simultaneous multiplexed pseudoimmunolabeling and imaging of human keratinocytes.C ore-shell MIP nanoparticles for GlcA and NANA,( 125 AE 17) nm in size, were obtained, thus enabling the specific targeting of both intracellular and pericellular terminal glycosylations.W e previously reported 400 nm rhodamine-labeled MIP particles specific for GlcA that could only target the extracellular hyaluronan of the cell glycocalix.…”